Latest filing published 27 Aug 2018 for GenMark Diagnostics, Inc., €6,600.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jennifer Anne Williams: trading record in brief
Jennifer Anne Williams is a declared insider of GenMark Diagnostics, Inc., with filings sourced from SEC (Form 4). The record holds 105 filings, for trades running from 3 November 2010 to 24 August 2018.
Both buying and selling appear: 2 purchases worth €23k, against 86 sales worth €2.9M. The net balance comes to €2.9M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 14 share grants and 3 option exercises. So far in 2018, the count stands at no purchases and 12 sales.
The latest filing, published on 27 August 2018, reports an open-market sale of €6,600 in GenMark Diagnostics, Inc. The latest purchase dates back some time: it was published 5,445 days ago, on 12 December 2011. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jennifer Anne Williams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,064 shares@ US$7.162.6% of flowCommon StockSEC:0001487371-18-000177:0
- 1,809 shares@ US$7.394.6% of flowCommon StockSEC:0001487371-18-000167:0
- 293 shares@ US$7.200.7% of flowCommon StockSEC:0001505035-18-000002:0
- 1,025 shares@ US$6.880.5% of flowCommon StockSEC:0001487371-18-000117:0
- 1,799 shares@ US$6.910.8% of flowCommon StockSEC:0001487371-18-000109:0
- 23,688 shares@ US$6.9011.0% of flowCommon StockSEC:0001487371-18-000101:0
- 300 shares@ US$6.180.1% of flowCommon StockSEC:0001487371-18-000093:0
- 367 shares@ US$4.000.1% of flowCommon StockSEC:0001487371-18-000066:0
- 80,750 shares0Common StockSEC:0001487371-18-000048:0
- 4,911 shares@ US$4.171.3% of flowCommon StockSEC:0001487371-18-000048:1
- 2,177 shares@ US$4.370.6% of flowCommon StockSEC:0001487371-18-000029:0
- 2,970 shares@ US$4.420.8% of flowCommon StockSEC:0001487371-18-000029:1
- 365 shares@ US$5.130.1% of flowCommon StockSEC:0001487371-18-000019:0
- 466 shares@ US$4.700.1% of flowCommon StockSEC:0001487371-17-000250:0
- 2,428 shares@ US$4.690.8% of flowCommon StockSEC:0001487371-17-000244:0
- 2,719 shares@ US$4.740.9% of flowCommon StockSEC:0001487371-17-000238:0
- 461 shares@ US$7.240.2% of flowCommon StockSEC:0001487371-17-000223:0
- 38,681 shares@ US$9.0823.5% of flowCommon StockSEC:0001487371-17-000195:0
- 335 shares@ US$9.750.2% of flowCommon StockSEC:0001487371-17-000191:0
- 1,972 shares@ US$9.451.3% of flowCommon StockSEC:0001487371-17-000179:0
- 341 shares@ US$10.330.2% of flowCommon StockSEC:0001487371-17-000165:0
- 333 shares@ US$12.890.3% of flowCommon StockSEC:0001487371-17-000140:0
- 1,954 shares@ US$12.891.8% of flowCommon StockSEC:0001487371-17-000114:0
- 329 shares@ US$13.340.3% of flowCommon StockSEC:0001487371-17-000098:0
- 525 shares@ US$12.180.5% of flowCommon StockSEC:0001487371-17-000075:0
25 of 102 declarations